Ondrey Aaron sold MRTX

January 23, 2024 · Form 4 insider transaction

Ondrey Aaron sold 11,993 shares of Mirati Therapeutics, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
11,993
Price
N/A
Total value
N/A
RoleOfficer
SecurityOption to Purchase Common Stock
Transaction codeD: Disposition to the issuer
Transaction dateJanuary 23, 2024
Filing dateJanuary 23, 2024
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Pursuant to the Merger Agreement, at the Effective Time, each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a Per Share Exercise Price that was equal to or greater than the Closing Consideration, but was less than the sum of the Closing Consideration and the maximum amount payable in respect of one CVR (the "Maximum Total Consideration"), was cancelled and converted into the right to receive a cash payment equal to (A) the excess of (x) the sum of (i) the Closing Consideration plus (ii) the actual Milestone Payment, if any, made in respect of one CVR over (y) the Per Share Exercise Price, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting).; Such payment will be made if, and only if, a Milestone Payment is made in respect of a CVR and will be made at the same time the Milestone Payment is made to holders of CVRs. If the CVR is terminated or expires without payment, no payment will be made with respect to any such Company Option.

View the original Form 4 on SEC EDGAR